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A six-month-old nulliparous, regularly cycling female
golden hamster (or Syrian hamster [Mesocricetus
auratus]) was admitted because of a continuous whitish
and bad smelling discharge from the vulva, as observed
by the owners two days after the end of the last estrus.
The history revealed that the animal was kept
together with two other male hamsters in separate
cages, thereby preventing mating. Body weight was
measured on a regular daily basis (always at 8 a.m.) by
the owners and ranged from 152 to 156 g. However, it
had increased to about 160 g on the day before
admission. The first estrous was seen at three months
of age, whereas regular estrous behavior had been
observed repeatedly every four–five days. The owners
reported a minor reduction in food intake and slight
polydipsia.
At clinical examination, the hamster was active and
in a good body condition. The gynecological exam
revealed a swollen vulva and the presence of muco-
purulent discharge. Gentle transabdominal palpation
(Bishop 2002) of the uterus led to small discharge of
exudate from the vulva immediately smeared and
stained with Hemacolor (Merck Chemicals,
Darmstadt, Germany). Microscopic examination of
the discharge showed the presence of mucopurulent
exudate with segmented neutrophils (Figure 1).
The owners approved ultrasound examination of the
urogenital tract by using a multi-frequency linear
probe array (7.5–10MHz)(MYLab 30 Esaote,
Genova, Italy). With the hamster placed in dorsal
recumbency, the uterine body and both horns
appeared to be dilated with a maximum diameter of
9mm and containing heterogenic fluid presenting
flocculation (Figure 2). The endometrium was thick-
ened (maximum thickness 4mm compared to 2mm
being the upper limit of reference range) and
hyperechoic.
Based on history, clinical signs, cytological, and
ultrasonographic findings, a diagnosis of pyometra
was conducted (Bishop 2002; Donnelly 2004;
Orcutt 2005; McKeon et al. 2011). Although ovario-
hysterectomy would have been the best and definitive
treatment option, the owners refused such and
requested an alternative treatment.
In dogs, a successful alternative to ovariohyster-
ectomy is aglepristone administration with no recog-
nized side effects (Fieni 2006). Although the
pathogenesis of pyometra in the current case was
unknown and considering also the satisfactory health
status of the patient, aglepristone treatment was
suggested to the owners. A signed informed consent
form was obtained from the owners for treatment with
aglepristone, a selective progesterone receptor antago-
nist. Due to the lack of protocols for aglepristone
(Alizin, Virbac, Milano, Italy) administration in
hamsters, an empiric dose of 20mg/kg BW was
chosen. The drug was injected subcutaneously on the
day of diagnosis and 24 hours later similar to the
protocol reported for dogs (Fieni 2006). An oral
broad-spectrum antibiotic therapy was also started
with marbofloxacin (Marbocyl, Ve´toquinol, Bertinoro,
Italy) prescribed at a dosage of 2mg/kg BW every
24 hours for 10 days.
The following day, prior to the second aglepristone
injection, a clinical examination showed that the
clinical status of the patient was unchanged.
Furthermore, the owners reported no changes, except
for a slight dysorexia and reduction of activity. As a
consequence, the second dose of aglepristone was
administered. The day after the second dose of
aglepristone, the owners reported the hamster had
restarted normal eating and also showed a restored
interest in playing with a wheel. No vulvar discharge
was noted, whereas the monitoring of body weight
evidenced a loss of 15 g. A clinical check on the seventh
day after the second dose of aglepristone showed a
marked improvement of health status with body
weight stabilized at 152 g. A repeated ultrasound
examination of the abdomen revealed the absence of
fluids within the lumen of the horns and body of the
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uterus, while the endometrium was still thickened, as
illustrated by a maximum thickness of 4mm. In
addition, a cystic endometrium was observed. Based
on these findings, aglepristone treatment was therefore
continued at day 8 by a further administration of
20mg/kg BW subcutaneously. As aglepristone in dogs
is associated with an open cervix, marbofloxacin
therapy was also continued in order to avoid possible
ascending uterine infections. On day 14, the patient
was healthy and the ultrasound examination revealed a
reduction of the endometrial layer of the uterine wall
with thickness still slightly elevated (maximum 3mm).
The cystic intra-wall structures were not detectable
anymore (Figure 3). A supplementary fourth aglepris-
tone injection was administered subcutaneously on day
15 to allow complete uterine involution. Two months
after the last treatment, the health status of the patient
was optimal, her body weight was stabilized and
estrous behavior was regularly observed again. The
long-term follow-up revealed that the hamster
Figure 2. Ultrasonographic examination of the uterine body and horns (dorsal recumbency, 10MHz multi-frequency linear
probe array): uterine body and horns dilated (maximum diameter 9mm) containing heterogenic fluid presenting flocculation.
Thickened (maximum thickness 4mm compared to 2mm being the upper limit of reference range) and hyperechoic endometrium
is visible.
Figure 1. Smear of vulvar discharge (Hemacolor staining): segmented neutrophils are observed within the mucopurulent
exudate.
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remained healthy and, although estrous behavior was
regularly observed, the owners did not allow the
hamster to mate, so that exact information about
fertility was not available.
Pyometra is a common disease of the uterus in
dogs. In the hamster, pyometra if not promptly
treated, can result in death (Bishop 2002; Donnelly
2004; Orcutt 2005). Ovariohysterectomy seems to be
the most appropriate option for the definitive treat-
ment of pyometra in the hamster (Bishop 2002;
Donnelly 2004; Fieni 2006; Capello 2011). Contrary
to the dog, the role of progesterone in the etiopatho-
genesis of pyometra in the hamster is not known. To
the authors’ knowledge, the efficacy of aglepristone
has not been tested in the hamster before, although it
might represent an interesting alternative to surgical
treatment. As the owners were reluctant to ovariohys-
terectomy, the present case was ‘‘empirically’’ treated
with aglepristone. Aglepristone treatment combined
with antibiotic administration turned out to be
effective in a hamster with pyometra. As no side
effects were observed, treatment was deemed safe also
considering the long-term stability as illustrated by the
observed regular estrous behavior without recurrence
of uterine disease.
This case report suggests that aglepristone treat-
ment can be considered as an alternative therapy to
ovariohysterectomy also in the hamster similar to other
species. Aglepristone might be suggested for high-risk
anesthetic patients or for patients in which fertility
should be maintained. In addition, the quick improve-
ment of the general condition seems to suggest the
usefulness of aglepristone administration prior to
ovariohysterectomy, as reported in dogs, in order
to stabilize the general condition of the patient and to
reduce the size of the uterus, thereby minimizing the
risk of intra-surgical uterine wall rupture.
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Figure 3. Ultrasonographic examination on day 14 (dorsal recumbency, 7.5MHz multi-frequency linear probe array): reduction
of the thickness of the endometrial layer of the uterine wall (maximum thickness 3mm) and the absence of cystic intra-wall
structures.
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